8-K
filed August 3, 2023, 7:59 PM ET
ticker SYK
CIK 0000310764
earnings
confidence high
sentiment positive
materiality 0.75
Stryker Q2 2023: Net sales +11.2% to $5.0B; adj. EPS $2.54; raises FY organic growth outlook to 9.5%-10.5%
STRYKER CORP
2023-Q2 EPS reported
$3.47
revenue$9,774,000,000
- Net sales $5.0B, +11.2% reported, +11.9% organic; adj. EPS $2.54 (+12.9%).
- MedSurg & Neurotechnology $2.9B (+12.9% organic); Orthopaedics & Spine $2.1B (+10.6% organic).
- Reported op margin 19.3%; adjusted op margin 24.3% (up 60bps).
- FY2023 organic sales growth guidance raised to 9.5%-10.5%; adj EPS guidance $10.25-$10.45.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
STRYKER CORP reported full year 2023 results: EPS $10.25 to $10.45. Guidance raised.
- Period
- full year 2023
- EPS
- $10.25 to $10.45
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
we now expect adjusted net earnings per diluted share (2) to be in the range of $10.25 to $10.45.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
STRYKER CORP reported second quarter 2023 results: revenue $5.0 billion.
- Period
- second quarter 2023
- Revenue
- $5.0 billion
- Result
- reported results
Exact text from the filing
Reported net earnings of $738 million increased 12.5% in the quarter. Reported net earnings per diluted share of $1.93 increased 12.2% in the quarter.
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
STRYKER CORP reported second quarter 2023 results: revenue $5.0 billion.
- Period
- second quarter 2023
- Revenue
- $5.0 billion
- Result
- reported results
Exact text from the filing
Reported net sales increased 11.2% to $5.0 billion
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.